Completed
Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
NCT02433795
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea
- Hallym University Medical Center Anyang-si, South Korea
- Chungnam National University Daejeon, South Korea
- Gachon University Gil Medical Center Incheon, South Korea